These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3893273)

  • 1. Piracetam plus lecithin trials in senile dementia of the Alzheimer type.
    Samorajski T; Vroulis GA; Smith RC
    Ann N Y Acad Sci; 1985; 444():478-81. PubMed ID: 3893273
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease.
    Smith RC; Vroulis G; Johnson R; Morgan R
    Psychopharmacol Bull; 1984; 20(3):542-5. PubMed ID: 6433396
    [No Abstract]   [Full Text] [Related]  

  • 3. Lecithin and piracetam in Alzheimer's disease.
    Davidson M; Mohs RC; Hollander E; Zemishlany Z; Powchik P; Ryan T; Davis KL
    Biol Psychiatry; 1987 Jan; 22(1):112-4. PubMed ID: 3790634
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of compounds for the treatment of memory dysfunction.
    Growdon JH; Corkin S; Huff FJ
    Ann N Y Acad Sci; 1985; 444():437-49. PubMed ID: 3893272
    [No Abstract]   [Full Text] [Related]  

  • 5. Piracetam combined with lecithin in the treatment of Alzheimer's disease.
    Growdon JH; Corkin S; Huff FJ; Rosen TJ
    Neurobiol Aging; 1986; 7(4):269-76. PubMed ID: 3528889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Romani A; Pola A; Zerbi F; Savoldi F
    Eur Arch Psychiatry Neurol Sci; 1989; 239(2):79-86. PubMed ID: 2478368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A; Rüster P; Romero B; Zimmer R
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
    Little A; Levy R; Chuaqui-Kidd P; Hand D
    J Neurol Neurosurg Psychiatry; 1985 Aug; 48(8):736-42. PubMed ID: 3897460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline.
    Parnetti L; Ciuffetti G; Mercuri M; Senin U
    Arch Gerontol Geriatr; 1985 Jul; 4(2):141-55. PubMed ID: 3899033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Psychopharmacol Bull; 1978 Jan; 14(1):23-5. PubMed ID: 343146
    [No Abstract]   [Full Text] [Related]  

  • 11. Involutional dementias: new perspectives.
    Borromei A; Gaggi R; Giancola LC
    Ital J Neurol Sci; 1985 Jun; 6(2):167-71. PubMed ID: 4030301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Piracetam in the treatment of alcohol-induced delirium].
    Snel H; Lehmann E; Velikonja M
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):947-9. PubMed ID: 6417503
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease.
    Jenike MA; Albert MS; Heller H; LoCastro S; Gunther J
    J Clin Psychiatry; 1986 May; 47(5):249-51. PubMed ID: 3700343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluctuations of free choline levels in plasma of Alzheimer patients receiving lecithin: preliminary observations.
    Chuaqui P; Levy R
    Br J Psychiatry; 1982 May; 140():464-9. PubMed ID: 7049290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases].
    Trabant R; Poljakovic Z; Trabant D
    Ther Ggw; 1977 Aug; 116(8):1504-21. PubMed ID: 331549
    [No Abstract]   [Full Text] [Related]  

  • 17. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
    Wettstein A
    Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 19. Double blind study of lecithin in patients with Alzheimer's disease.
    Fisman M; Merskey H; Helmes E; McCready J; Colhoun EH; Rylett BJ
    Can J Psychiatry; 1981 Oct; 26(6):426-8. PubMed ID: 7028239
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholinergic effects on constructional abilities and on mnemonic processes: a case report.
    Sahakian B; Joyce E; Lishman WA
    Psychol Med; 1987 May; 17(2):329-33. PubMed ID: 3299440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.